FDA Inspection
Nippon Shikizai, Inc.Nippon Shikizai, Inc. – FDA Inspection, Sep 12, 2025
Record Details
This FDA Inspection record concerns Nippon Shikizai, Inc., with an inspection on September 12, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · a7725f60-1cf1-40b1-ab4c-46cb2c157bbf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1283264
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.166(a)(3)Valid stability test methods
- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.182Specific information required in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nippon Shikizai, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nippon Shikizai, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.